We use cookies to give you the best experience on our website. If you are happy with the use of these cookies please click acknowledge & accept. Alternatively, you can find more information in our
privacy statement
, or
decline optional cookies
.
Acknowledge & Accept
FAQ | Eramol
Let's Talk
Clinical Services
Placebo manufacturing
Matched placebo tablets
Over-Encapsulation
Liquid blinding
EU & UK Importation
UK Verification process for EU QP supply chains
EU & UK sites of physical importation
IOR & Customs clearance services
IMP importation after Brexit
EU & UK QP Release
QP Auditing
Seamless transition
Rest of World Release
QP Support
Clinical Packaging
Clinical Primary Packaging
Clinical Secondary Packaging
Commercial Drug Procurement
Sourcing of Commercial Actives
Global sourcing
Formulation Development
Placebo Formulation Development
Analytical method development & stability studies
Pre-GMP formulation
GMP transfer and scale up
Deformulation & characterisation
Labelling solutions
Just in time labelling
Multi-lingual Booklet
Clinical Storage & Distribution
Storage
Locations
IOR & Customs services
Brexit solutions
Clinical Supply Chain Solutions
Supply chain assessments
Temperature controlled shipments
Resources
Careers
About
Company
People
Our Approach
Carbon Reduction Plan
Accreditations
Contact
Search
Home
>
Resources
>
FAQ
FAQ
Q.
my question
A.
my answer
Q.
question 2
A.
answer 2
Back To Home
